Search results
...Algorithm for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF), Met All...
VentureBeat· 17 hours agoPress Release BaroPace Inc. announces its Phase I first-in-human trial of PressurePaceTM, its...
2024 HFMC CME Symposium - Managing Worsening Heart Failure with Reduced Ejection Fraction:...
Digital Journal· 6 days agoJun. 13, 2024 / PRZen / HAZLET, N.J. -- In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained. A panel discussion ...
Heart Failure in Women: Key Differences and Clinical Tips
Medscape· 5 days agoCurrently, there are 6.7 million Americans with heart failure, and approximately 45% of them are...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 6 days agoFurther regulatory submissions and market evaluations are underway to determine additional rollout...
Delays After Tests for Suspected Heart Failure 'a Scandal'
Medscape· 2 days agoFew people with suspected heart failure and elevated N-terminal prohormone of brain natriuretic...
Daughter of the legendary James Brown battles heart failure
Waterloo-Cedar Falls Courier· 7 days agoDeanna Brown-Thomas was at her desk at the James Brown Family Foundation in Augusta, Georgia, when her chest began tightening. The daughter of the legendary Godfather of Soul called Velice Cummings ...
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure,...
Digital Journal· 7 days agoRenova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart ...
NCH piloting the use of smart stethoscopes
WINK TV Southwest Florida· 4 days agoNow, thanks to artificial intelligence, the stethoscope just got a whole lot smarter. Today, the tried-and-true stethoscope is turning into a handheld...
Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Down 34.7% in May
ETF DAILY NEWS· 6 days agoTenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling ...
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) to Post Q2 2024 Earnings of ($0.37) Per Share, William Blair...
ETF DAILY NEWS· 6 days agoTenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) – Research analysts at William Blair issued their Q2 2024 EPS estimates for shares of Tenaya Therapeutics in a research note issued on Monday ...
